Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00537810 · ClinicalTrials.gov registry record · Phase 4
Treatment of Binge Eating in Obese Patients in Primary Care
A Phase 4 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 4
- Development phase
- 104
- Enrollment target
NCT00537810 is a Phase 4 study that has completed, run by Yale University. The registered enrollment target is 104 participants.
The verdict
NCT00537810, a Phase 4 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 104 participants
- Enrollment target
Study Summary
This study will test the effectiveness of two empirically-supported but distinct treatments for recurrent binge eating in obese patients: 1) Cognitive Behavior Therapy, using a pure self-help approach and 2) sibutramine, an anti-obesity medication also found to have efficacy for binge eating. Self-help Cognitive Behavior Therapy and sibutramine will be administered alone and in combination in a primary care setting.
Interventions
- DRUG Placebo
- DRUG Sibutramine
- BEHAVIORAL Self-help CBT + Sibutramine
- BEHAVIORAL Self-help CBT + Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2007-09 |
| Est. Completion | 2012-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00537810
The ClinicalTrials.gov registry entry for NCT00537810 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00537810 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00537810 about?
NCT00537810 is a clinical study titled "Treatment of Binge Eating in Obese Patients in Primary Care". This study will test the effectiveness of two empirically-supported but distinct treatments for recurrent binge eating in obese patients: 1) Cognitive Behavior Therapy, using a pure self-help approach and 2) sibutramine, an anti-obesity medication also found to have efficacy for binge eating. Self-h...
What is the current status of trial NCT00537810?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 104 participants. The study started on 2007-09. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00537810?
The interventions under investigation include: Placebo (DRUG), Sibutramine (DRUG), Self-help CBT + Sibutramine (BEHAVIORAL), Self-help CBT + Placebo (BEHAVIORAL).
Who is sponsoring clinical trial NCT00537810?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.